{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:40:52Z","timestamp":1793608852378,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["955756"],"award-info":[{"award-number":["955756"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.xphs.2025.103911","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:29:05Z","timestamp":1752852545000},"page":"103911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessing potential of precipitation inhibitors to prevent precipitation during dispersion and digestion of lipid-based formulations using in-line analytics"],"prefix":"10.1016","volume":"114","author":[{"given":"Lotte","family":"Ejskj\u00e6r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Kimpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2293-8020","authenticated-orcid":false,"given":"Hugo","family":"Bohets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bevernage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5433-8398","authenticated-orcid":false,"given":"Brendan T.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-8364","authenticated-orcid":false,"given":"Patrick J.","family":"O\u2019Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103911_bib0001","doi-asserted-by":"crossref","unstructured":"Alvebratt, C., Keemink, J., Edueng, K., Cheung, O., Str\u00f8mme, M., & Bergstr\u00f6m, C.A.S. (2020). An in vitro dissolution-digestion-permeation assay for the study of advanced drug delivery systems. https:\/\/doi.org\/10.1016\/j.ejpb.2020.01.010.","DOI":"10.1016\/j.ejpb.2020.01.010"},{"key":"10.1016\/j.xphs.2025.103911_bib0002","doi-asserted-by":"crossref","unstructured":"Anby, M.U., Williams, H.D., Mcintosh, M., Benameur, H., Edwards, G.A., Pouton, C.W., & Porter, C.J.H. (2012). Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. https:\/\/doi.org\/10.1021\/mp300164u.","DOI":"10.1021\/mp300164u"},{"issue":"1","key":"10.1016\/j.xphs.2025.103911_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jps.22750","article-title":"Supersaturating drug delivery systems: fast is not necessarily good enough","volume":"101","author":"Augustijns","year":"2012","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103911_bib0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.xphs.2020.10.055","article-title":"Applying computational predictions of biorelevant solubility ratio upon self-emulsifying lipid-based formulations dispersion to predict dose number","volume":"110","author":"Bennett-Lenane","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103911_bib0005","first-page":"141","article-title":"Biorelevant dissolution testing of a weak base: interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation","volume":"140","author":"Berben","year":"2019","journal-title":"Off J Arbeitsgemeinschaft Fur Pharm Verfahrenstechnik eV"},{"issue":"3","key":"10.1016\/j.xphs.2025.103911_bib0006","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1208\/pt0803052","article-title":"Monitoring ibuprofen release from multiparticulates: in situ fiber-optic technique versus the HPLC method: a technical note","volume":"8","author":"Bijlani","year":"2007","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.xphs.2025.103911_bib0007","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","article-title":"Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?","volume":"98","author":"Brouwers","year":"2009","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103911_bib0008","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2007.01.017","article-title":"The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats","volume":"67","author":"Dahan","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2025.103911_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106833","article-title":"Predictions of biorelevant solubility change during dispersion and digestion of lipid-based formulations","volume":"200","author":"Ejskj\u00e6r","year":"2024","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103911_bib0010","article-title":"Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations","author":"Ejskj\u00e6r","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103911_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106681","article-title":"Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations","volume":"194","author":"Ejskj\u00e6r","year":"2024","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103911_bib0012","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jps.21451","article-title":"Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption","volume":"98","author":"Gao","year":"2009","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103911_bib0013","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1081\/DDC-120028718","article-title":"Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations","volume":"30","author":"Gao","year":"2004","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103911_bib0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/17425247.3.1.97","article-title":"Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs","volume":"3","author":"Gao","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"issue":"12","key":"10.1016\/j.xphs.2025.103911_bib0015","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.10511","article-title":"Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability","volume":"92","author":"Gao","year":"2003","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2025.103911_bib0016","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/jps.20906","article-title":"Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations","volume":"96","author":"Guzm\u00e1n","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103911_bib0017","doi-asserted-by":"crossref","unstructured":"H Porter, C.J., Marie Kaukonen, A., Boyd, B.J., Edwards, G.A., & Charman, W.N. (2004). Susceptibility to lipase-mediated digestion reduces the oral bioavailability of Danazol after administration as a medium-chain lipid-based microemulsion formulation.","DOI":"10.1023\/B:PHAM.0000036914.22132.cc"},{"key":"10.1016\/j.xphs.2025.103911_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106556","article-title":"Lipid based formulations as supersaturating oral delivery systems: from current to future industrial applications","volume":"189","author":"Holm","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103911_bib0019","series-title":"Surfactants and Polymers in Aqueous Solution","author":"Holmberg","year":"2003"},{"key":"10.1016\/j.xphs.2025.103911_bib0020","doi-asserted-by":"crossref","unstructured":"Kaukonen, A.M., Boyd, B.J., Charman, W.N., & Porter, C.J.H. (2004). Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.","DOI":"10.1023\/B:PHAM.0000016283.87709.a9"},{"issue":"3","key":"10.1016\/j.xphs.2025.103911_bib0021","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acs.molpharmaceut.8b00811","article-title":"Lipolysis-permeation setup for simultaneous study of digestion and absorption in vitro","volume":"16","author":"Keemink","year":"2019","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2025.103911_bib0022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2478\/acph-2024-0023","article-title":"Lipid-based systems with precipitation inhibitors as formulation approach to improve the drug bioavailability and\/or lower its dose: a review","volume":"74","author":"Kovacevic","year":"2024","journal-title":"Acta Pharm"},{"key":"10.1016\/j.xphs.2025.103911_bib0023","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2018.11.003","article-title":"Drug supersaturation during formulation digestion, including real-time analytical approaches","volume":"142","author":"Kuentz","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.xphs.2025.103911_bib0024","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jcis.2008.05.034","article-title":"Nucleation and crystal growth in supersaturated solutions of a model drug","volume":"325","author":"Lindfors","year":"2008","journal-title":"J Colloid Interface Sci"},{"issue":"3","key":"10.1016\/j.xphs.2025.103911_bib0025","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jps.21481","article-title":"Comprehensive validation scheme for In situ Fiber optics dissolution method for pharmaceutical drug product testing","volume":"98","author":"Mirza","year":"2009","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2025.103911_bib0026","first-page":"365","article-title":"Current status of supersaturable self-emulsifying drug delivery systems","volume":"12","author":"Park","year":"2020","journal-title":"Pharm 2020"},{"issue":"2","key":"10.1016\/j.xphs.2025.103911_bib0027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/adt.2012.466","article-title":"Evaluation of a high-throughput screening method for the detection of the excipient-mediated precipitation inhibition of poorly soluble drugs","volume":"11","author":"Petru\u0161evska","year":"2013","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.xphs.2025.103911_bib0028","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/acs.molpharmaceut.7b00419","article-title":"Investigation of the intra-and interlaboratory reproducibility of a small scale standardized supersaturation and precipitation method","volume":"14","author":"Plum","year":"2017","journal-title":"Mol Pharm"},{"issue":"SUPPL. 2","key":"10.1016\/j.xphs.2025.103911_bib0029","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur J Pharm Sci"},{"issue":"3\u20134","key":"10.1016\/j.xphs.2025.103911_bib0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103911_bib0031","doi-asserted-by":"crossref","unstructured":"Price, D.J., Ditzinger, F., Koehl, N.J., Jankovic, S., Tsakiridou, G., Nair, A., Holm, R.E., Kuentz, M., Dressman, J.B., & Saal, C. (2018). Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations-a PEARRL review. https:\/\/doi.org\/10.1111\/jphp.12927.","DOI":"10.1111\/jphp.12927"},{"issue":"6","key":"10.1016\/j.xphs.2025.103911_bib0032","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1021\/acs.molpharmaceut.8b00206","article-title":"Polymeric precipitation inhibitors promote fenofibrate supersaturation and enhance drug absorption from a type IV lipid-based formulation","volume":"15","author":"Suys","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2025.103911_bib0033","doi-asserted-by":"crossref","unstructured":"Warren, D.B., Benameur, H., Porter, C.J.H., & Pouton, C.W. (2010). Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. , 18 (10), 704\u2013731. https:\/\/doi.org\/10.3109\/1061186X.2010.525652.","DOI":"10.3109\/1061186X.2010.525652"},{"key":"10.1016\/j.xphs.2025.103911_bib0034","doi-asserted-by":"crossref","unstructured":"Williams, H.D., Sassene, P., Kleberg, K., Bakala-N Goma, J.C., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., Vertommen, J., Maio, M., Blundell, R., Benameur, H., Carri\u00e9re, F., Mullertz, A., Porter, C.J.H., & Pouton, C.W. (2012). Toward the establishment of standardized In vitro tests for lipid-based formulations, part 1: method parameterization and comparison of In vitro digestion profiles across a range of representative formulations. https:\/\/doi.org\/10.1002\/jps.23205.","DOI":"10.1002\/jps.23205"},{"key":"10.1016\/j.xphs.2025.103911_bib0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpharm.2013.05.013","article-title":"Review drug precipitation inhibitors in supersaturable formulations","volume":"453","author":"Xu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103911_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106684","article-title":"A comparison of USP 2 and \u00b5DISS ProfilerTM apparatus for studying dissolution phenomena of ibuprofen and its salts","volume":"193","author":"Z\u00f6ller","year":"2024","journal-title":"Eur J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925003636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925003636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:53:46Z","timestamp":1772790826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925003636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0022354925003636"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103911","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing potential of precipitation inhibitors to prevent precipitation during dispersion and digestion of lipid-based formulations using in-line analytics","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"103911"}}